LEP and hepatocellular carcinoma: Leptin activates oncogenic signaling pathways, such as PI3K/Akt, MAPK, and STAT3 and upregulates human telomerase reverse transcriptase (hTERT), a mediator of cellular immortalization, in HCC cells [281,282].